allodynia caused by semaglutide is being reported with GLP-1 medications, It is a heightened sensitivity to touch that can feel like pain. We are seeing it more at higher doses, The important point is that it appears allodynia caused by semaglutide What

In the pivotal STEP 1 clinical trial, participants who received weekly semaglutide injections lost an average of 14.9% of their body weight over 68 weeks , compared with 2.4% in the placebo group (study in the New England Journal of Medicine )

How to take GLP-1 medications safely and effectively: Work with a knowledgeable medical provider: Because Hashimotos is a complex autoimmune disease, its essential to work with a provider who understands how to tailor GLP-1 treatment to your unique needs

However, the Bridge program will pay for these drugs only when used specifically for weight loss

doi: 10.1016/j.meafoo.2023.100078 29

What we can promise is professional, safe treatment delivered with mobile convenience